These changes were associated with premature death and more severe seizures in B6J mice heterozygous for deletion of the Dravet syndrome candidate gene Scn1a relative to corrected lines heterozygous for the same deletion. The gene discussed is SCN1A; the disease is encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy.